Persistent effect of arimoclomol in patients with Niemann-Pick disease type C: 24-month results from an open-label extension of a pivotal phase 2/3 study
Authors:
- Marc PattersonMPMarc Patterson
- Eugen MengelEMEugen Mengel
- Rosalia M. Da RioRRRosalia M. Da Rio
- Mireia Del ToroMTMireia Del Toro
- Federica DeodatoFDFederica Deodato
- Matthias GautschiMGMatthias Gautschi
- Stephanie GrunewaldSGStephanie Grunewald
- Sabine GrønborgSGSabine Grønborg
- Paul HarmatzPHPaul Harmatz
- Bénédicte HéronBHBénédicte Héron
- Esther M. MaierEMEsther M. Maier
- Agathe RoubertieARAgathe Roubertie
- 3 February 2022
- journal article
- abstracts
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 135 (2) , S94